InsidersTradesSigma
Track the エーザイ株式会社 share price and the full management transaction log of the company, a listed issuer based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Market capitalisation: €1,256bn. The latest transaction was filed on 21 July 2026 (Holding update). Among the most active insiders: BlackRock Japan Co., Ltd.. The full history is openly available.
Analysts rate エーザイ株式会社 Buy (bullish), based on 14 analysts. Average price target: JP¥4,482.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Eisai Co., Ltd. is a Japanese pharmaceutical company focused on the research and development of medications, particularly for neurological diseases. It is listed on the Tokyo Stock Exchange under the symbol XTKS.